Skip to main content

Advertisement

SpringerLink
Log in

Surgery for malignant lesions of the chest which extensively involved the mediastinum, lung, and heart

  • Current Topics Review Article
  • Published:
General Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Objective

Radical resection for thoracic malignancies that invade the great vessels or heart structure is an uncommon, high-risk operation. To help surgeons determine therapeutic strategy, we reviewed the patient characteristics and outcomes of combined thoracic and cardiovascular surgery for thoracic malignancies.

Methods

Surgical resections of lung cancer, mediastinal tumor and pulmonary artery sarcoma invading great vessels or heart structures were reviewed from the literature.

Results

Pneumonectomy was often performed for lung cancer invading the aorta, superior vena cava, and left atrium. Complete resection (R0), no mediastinal lymph node metastasis and without using cardiopulmonary bypass led to a good prognosis. Induction therapy was often performed for complete resection. Regarding mediastinal tumors, thymic epithelial tumors or germ cell tumors occasionally invaded the great vessels or heart structures. For these malignancies, multimodality therapy was often performed, and complete resection could be one of the prognostic factors. The resection of primary pulmonary artery sarcoma (PPAS) is also a combined thoracic and cardiovascular surgery. The primary treatment for PPAS is surgical resection; specifically, pulmonary endarterectomy and pneumonectomy, because PPAS has substantial resistance to chemotherapy or radiotherapy. The prognosis of PPAS is poor, but surgical resection has potential for long-term survival.

Conclusion

Although these surgeries are uncommon and invasive for the patients, selecting appropriate patients, aggressive multimodality therapy, and performing combined thoracic and cardiovascular surgery can contribute to a good outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Masuda M, Okumura M, Doki Y, Endo S, Hirata Y, Kobayashi J, et al. Thoracic and cardiovascular surgery in Japan during 2014: annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg. 2016;64:665–97.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Borri A, Leo F, Veronesi G, Solli P, Galetta D, Gasparri R, et al. Extended pneumonectomy for non-small cell lung cancer: morbidity, mortality, and long-term results. J Thorac Cardiovasc Surg. 2007;134:1266–72.

    Article  PubMed  Google Scholar 

  3. Masuda M, Kuwano H, Okumura M, Arai H, Endo S, Doki Y, et al. Thoracic and cardiovascular surgery in Japan during 2013: annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg. 2015;63:670–701.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Watanabe S, Asamura H, Miyaoka E, Okumura M, Yoshino I, Fujii Y, et al. Results of T4 surgical cases in the Japanese Lung Cancer Registry Study: should mediastinal fat tissue invasion really be included in the T4 category? J Thorac Oncol. 2013;8:759–65.

    Article  PubMed  Google Scholar 

  5. Vaporciyan AA, Rice D, Correa AM, Walsh G, Putnam JB, Swisher S, et al. Resection of advanced thoracic malignancies requiring cardiopulmonary bypass. Eur J Cardiothorac Surg. 2002;22:47–52.

    Article  PubMed  Google Scholar 

  6. de Perrot M, Fadel E, Mussot S, de Palma A, Chapelier A, Dartevelle P. Resection of locally advanced (T4) non-small cell lung cancer with cardiopulmonary bypass. Ann Thorac Surg. 2005;79:1691–6 (discussion 97).

  7. Arif R, Eichhorn F, Kallenbach K, Seppelt P, Ruhparwar A, Dienemann H, et al. Resection of thoracic malignancies infiltrating cardiac structures with use of cardiopulmonary bypass. J Cardiothorac Surg. 2015;10:87.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Muralidaran A, Detterbeck FC, Boffa DJ, Wang Z, Kim AW. Long-term survival after lung resection for non-small cell lung cancer with circulatory bypass: a systematic review. J Thorac Cardiovasc Surg. 2011;142:1137–42.

    Article  PubMed  Google Scholar 

  9. Stamatis G, Eberhardt W, Stuben G, Bildat S, Dahler O, Hillejan L. Preoperative chemoradiotherapy and surgery for selected non-small cell lung cancer IIIB subgroups: long-term results. Ann Thorac Surg. 1999;68:1144–9.

    Article  CAS  PubMed  Google Scholar 

  10. Wiebe K, Baraki H, Macchiarini P, Haverich A. Extended pulmonary resections of advanced thoracic malignancies with support of cardiopulmonary bypass. Eur J Cardiothorac Surg. 2006;29:571–7 (discussion 77–8).

  11. Brierley JD, Gospodarowicz MK, Wittekind C. Union for international cancer control (UICC) TNM classification of malignant tumors. 8th ed. NJ: Wiley Blackwell; 2017.

    Google Scholar 

  12. Yildizeli B, Dartevelle PG, Fadel E, Mussot S, Chapelier A. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk. Ann Thorac Surg. 2008;86:1065–75 (discussion 74–5).

  13. Tsuchiya R, Asamura H, Kondo H, Goya T, Naruke T. Extended resection of the left atrium, great vessels, or both for lung cancer. Ann Thorac Surg. 1994;57:960–5.

    Article  CAS  PubMed  Google Scholar 

  14. Fukuse T, Wada H, Hitomi S. Extended operation for non-small cell lung cancer invading great vessels and left atrium. Eur J Cardiothorac Surg. 1997;11:664–9.

    Article  CAS  PubMed  Google Scholar 

  15. Klepetko W, Wisser W, Birsan T, Mares P, Taghavi S, Kupilik N, et al. T4 lung tumors with infiltration of the thoracic aorta: is an operation reasonable? Ann Thorac Surg. 1999;67:340–4.

    Article  CAS  PubMed  Google Scholar 

  16. Ohta M, Hirabayasi H, Shiono H, Minami M, Maeda H, Takano H, et al. Surgical resection for lung cancer with infiltration of the thoracic aorta. J Thorac Cardiovasc Surg. 2005;129:804–8.

    Article  PubMed  Google Scholar 

  17. Misthos P, Papagiannakis G, Kokotsakis J, Lazopoulos G, Skouteli E, Lioulias A. Surgical management of lung cancer invading the aorta or the superior vena cava. Lung Cancer (Amsterdam, Netherlands). 2007;56:223–7.

    Article  CAS  Google Scholar 

  18. Nagata T, Nakamura Y, Yamamoto H, Sato M. A fenestrated stent graft for surgical resection of lung cancer invading the aortic arch. J Thorac Cardiovasc Surg. 2013;146:238–9.

    Article  PubMed  Google Scholar 

  19. Collaud S, Waddell TK, Yasufuku K, Oreopoulos G, Rampersaud R, Rubin B et al. Thoracic aortic endografting facilitates the resection of tumors infiltrating the aorta. J Thorac Cardiovasc Surg. 2014;147:1178–82 (discussion 82).

  20. Marulli G, Rea F, Zampieri D, Antonello M, Maurizi G, Venuta F, et al. Safe resection of the aortic wall infiltrated by lung cancer after placement of an endoluminal prosthesis. Ann Thorac Surg. 2015;99:1768–73.

    Article  PubMed  Google Scholar 

  21. Kusumoto H, Shintani Y, Funaki S, Inoue M, Okumura M, Kuratani T, et al. Combined resection of great vessels or the heart for non-small lung cancer. Ann Thorac Cardiovasc Surg. 2015;21:332–7.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Marulli G, Lepidi S, Frigatti P, Antonello M, Grego F, Rea F. Thoracic aorta endograft as an adjunct to resection of a locally invasive tumor: a new indication to endograft. J Vasc Surg. 2008;47:868–70.

    Article  PubMed  Google Scholar 

  23. Nation DA, Wang GJ. TEVAR: endovascular repair of the thoracic aorta. Semin Interv Radiol. 2015;32:265–71.

    Article  Google Scholar 

  24. Tadros RO, Lipsitz EC, Chaer RA, Faries PL, Marin ML, Cho JS. A multicenter experience of the management of collapsed thoracic endografts. J Vasc Surg. 2011;53:1217–22.

    Article  PubMed  Google Scholar 

  25. Spaggiari L, Leo F, Veronesi G, Solli P, Galetta D, Tatani B et al. Superior vena cava resection for lung and mediastinal malignancies: a single-center experience with 70 cases. Ann Thorac Surg. 2007;83:223–9 (discussion 29–30).

  26. Leo F, Bellini R, Conti B, Delledonne V, Tavecchio L, Pastorino U. Superior vena cava resection in thoracic malignancies: does prosthetic replacement pose a higher risk? Eur J Cardiothorac Surg. 2010;37:764–9.

    Article  PubMed  Google Scholar 

  27. Sekine Y, Suzuki H, Saitoh Y, Wada H, Yoshida S. Prosthetic reconstruction of the superior vena cava for malignant disease: surgical techniques and outcomes. Ann Thorac Surg. 2010;90:223–8.

    Article  PubMed  Google Scholar 

  28. Masuda H, Ogata T, Kikuchi K. Physiological changes during temporary occlusion of the superior vena cava in cynomolgus monkeys. Ann Thorac Surg. 1989;47:890–6.

    Article  CAS  PubMed  Google Scholar 

  29. Dartevelle PG. Herbert Sloan Lecture. Extended operations for the treatment of lung cancer. Ann Thorac Surg. 1997;63:12–9.

    Article  CAS  PubMed  Google Scholar 

  30. Shintani Y, Ohta M, Minami M, Shiono H, Hirabayashi H, Inoue M, et al. Long-term graft patency after replacement of the brachiocephalic veins combined with resection of mediastinal tumors. J Thorac Cardiovasc Surg. 2005;129:809–12.

    Article  PubMed  Google Scholar 

  31. Lanuti M, De Delva PE, Gaissert HA, Wright CD, Wain JC, Allan JS, et al. Review of superior vena cava resection in the management of benign disease and pulmonary or mediastinal malignancies. Ann Thorac Surg. 2009;88:392–7.

    Article  PubMed  Google Scholar 

  32. D’Andrilli A, Ciccone AM, Ibrahim M, Venuta F, Rendina EA. A new technique for prosthetic reconstruction of the superior vena cava. J Thorac Cardiovasc Surg. 2006;132:192–4.

    Article  PubMed  Google Scholar 

  33. Shargall Y, de Perrot M, Keshavjee S, Darling G, Ginsberg R, Johnston M, et al. 15 years single center experience with surgical resection of the superior vena cava for non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 2004;45:357–63.

    Article  Google Scholar 

  34. Spaggiari L, Magdeleinat P, Kondo H, Thomas P, Leon ME, Rollet G, et al. Results of superior vena cava resection for lung cancer. Analysis of prognostic factors. Lung Cancer (Amsterdam, Netherlands). 2004;44:339–46.

    Article  Google Scholar 

  35. Suzuki K, Asamura H, Watanabe S, Tsuchiya R. Combined resection of superior vena cava for lung carcinoma: prognostic significance of patterns of superior vena cava invasion. Ann Thorac Surg. 2004;78:1184–9 (discussion 84–9).

  36. Ratto GB, Costa R, Vassallo G, Alloisio A, Maineri P, Bruzzi P. Twelve-year experience with left atrial resection in the treatment of non-small cell lung cancer. Ann Thorac Surg. 2004;78:234–7.

    Article  PubMed  Google Scholar 

  37. Spaggiari L, D’Aiuto M, Veronesi G, Pelosi G, de Pas T, Catalano G, et al. Extended pneumonectomy with partial resection of the left atrium, without cardiopulmonary bypass, for lung cancer. Ann Thorac Surg. 2005;79:234–40.

    Article  PubMed  Google Scholar 

  38. Wu L, Xu Z, Zhao X, Li J, Zhong L, Pang T, et al. Surgical treatment of lung cancer invading the left atrium or base of the pulmonary vein. World J Surg. 2009;33:492–6.

    Article  PubMed  Google Scholar 

  39. Kuehnl A, Lindner M, Hornung HM, Winter H, Jauch KW, Hatz RA, et al. Atrial resection for lung cancer: morbidity, mortality, and long-term follow-up. World J Surg. 2010;34:2233–9.

    Article  PubMed  Google Scholar 

  40. Stella F, Dell’Amore A, Caroli G, Dolci G, Cassanelli N, Luciano G, et al. Surgical results and long-term follow-up of T(4)-non-small cell lung cancer invading the left atrium or the intrapericardial base of the pulmonary veins. Interact Cardiovasc Thorac Surg. 2012;14:415–9.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Galvaing G, Tardy MM, Cassagnes L, Da Costa V, Chadeyras JB, Naamee A, et al. Left atrial resection for T4 lung cancer without cardiopulmonary bypass: technical aspects and outcomes. Ann Thorac Surg. 2014;97:1708–13.

    Article  PubMed  Google Scholar 

  42. Tsukioka T, Takahama M, Nakajima R, Kimura M, Inoue H, Yamamoto R. Surgical outcome of patients with lung cancer involving the left atrium. Int J Clin Oncol. 2016;21:1046–50.

    Article  PubMed  Google Scholar 

  43. Macchiarini P, Chapelier AR, Monnet I, Vannetzel JM, Rebischung JL, Cerrina J, et al. Extended operations after induction therapy for stage IIIb (T4) non-small cell lung cancer. Ann Thorac Surg. 1994;57:966–73.

    Article  CAS  PubMed  Google Scholar 

  44. Reymen B, van Baardwijk A, Wanders R, Borger J, Dingemans AM, Bootsma G, et al. Long-term survival of stage T4N0-1 and single station IIIA-N2 NSCLC patients treated with definitive chemo-radiotherapy using individualised isotoxic accelerated radiotherapy (INDAR). Radiother Oncol. 2014;110:482–7.

    Article  CAS  PubMed  Google Scholar 

  45. Kondo K. Therapy for thymic epithelial tumors. Gen Thorac Cardiovasc Surg. 2014;62:468–74.

    Article  PubMed  Google Scholar 

  46. De Giacomo T, Patella M, Mazzesi G, Venuta F. Successful resection of thymoma directly invading the right atrium under cardiopulmonary bypass. Eur J Cardiothorac Surg. 2015;48:332–3.

    Article  PubMed  Google Scholar 

  47. Ohata K, Yoshimura T, Matsubara Y, Yasuhara Y, Terada Y. Invasive thymoma protruding into the superior vena cava through the thymic vein. Ann Thorac Cardiovasc Surg. 2016;22:122–4.

    Article  PubMed  Google Scholar 

  48. Detterbeck FC, Stratton K, Giroux D, Asamura H, Crowley J, Falkson C, et al. The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol. 2014;9:S65–72.

    Article  PubMed  Google Scholar 

  49. Ruffini E, Detterbeck F, Van Raemdonck D, Rocco G, Thomas P, Weder W, et al. Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons database. J Thorac Oncol. 2014;9:541–8.

    Article  PubMed  Google Scholar 

  50. Omasa M, Date H, Sozu T, Sato T, Nagai K, Yokoi K, et al. Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors: the Japanese Association for Research on the Thymus Database Study. Cancer. 2015;121:1008–16.

    Article  PubMed  Google Scholar 

  51. Ruffini E, Detterbeck F, Van Raemdonck D, Rocco G, Thomas P, Weder W, et al. Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database. Eur J Cardiothorac Surg. 2014;46:361–8.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Jackson MW, Palma DA, Camidge DR, Jones BL, Robin TP, Sher DJ, et al. The impact of postoperative radiotherapy for thymoma and thymic carcinoma. J Thorac Oncol. 2017;12:734–44.

    Article  PubMed  Google Scholar 

  53. Lim YJ, Kim HJ, Wu HG. Role of postoperative radiotherapy in nonlocalized thymoma: propensity-matched analysis of surveillance, epidemiology, and end results database. J Thorac Oncol. 2015;10:1357–63.

    Article  PubMed  Google Scholar 

  54. Zhou D, Deng XF, Liu QX, Zheng H, Min JX, Dai JG. The effectiveness of postoperative radiotherapy in patients with completely resected thymoma: a meta-analysis. Ann Thorac Surg. 2016;101:305–10.

    Article  PubMed  Google Scholar 

  55. Rimner A, Yao X, Huang J, Antonicelli A, Ahmad U, Korst RJ, et al. Postoperative radiation therapy is associated with longer overall survival in completely resected stage II and III thymoma—an analysis of the International Thymic Malignancies Interest Group Retrospective Database. J Thorac Oncol. 2016;11:1785–92.

    Article  PubMed  Google Scholar 

  56. Korst RJ, Kansler AL, Christos PJ, Mandal S. Adjuvant radiotherapy for thymic epithelial tumors: a systematic review and meta-analysis. Ann Thorac Surg. 2009;87:1641–7.

    Article  PubMed  Google Scholar 

  57. Utsumi T, Shiono H, Kadota Y, Matsumura A, Maeda H, Ohta M, et al. Postoperative radiation therapy after complete resection of thymoma has little impact on survival. Cancer. 2009;115:5413–20.

    Article  PubMed  Google Scholar 

  58. Nakamura Y, Matsumura A, Katsura H, Sakaguchi M, Ito N, Kitahara N, et al. Cisplatin-based chemotherapy followed by surgery for malignant nonseminomatous germ cell tumor of mediastinum: one institution’s experience. Gen Thorac Cardiovasc Surg. 2009;57:363–8.

    Article  PubMed  Google Scholar 

  59. Kang CH, Kim YT, Jheon SH, Sung SW, Kim JH. Surgical treatment of malignant mediastinal nonseminomatous germ cell tumor. Ann Thorac Surg. 2008;85:379–84.

    Article  PubMed  Google Scholar 

  60. Kesler KA, Rieger KM, Hammoud ZT, Kruter LE, Perkins SM, Turrentine MW, et al. A 25-year single institution experience with surgery for primary mediastinal nonseminomatous germ cell tumors. Ann Thorac Surg. 2008;85:371–8.

    Article  PubMed  Google Scholar 

  61. Fizazi K, Culine S, Droz JP, Terrier-Lacombe MJ, Theodore C, Wibault P, et al. Initial management of primary mediastinal seminoma: radiotherapy or cisplatin-based chemotherapy? Eur J Cancer (Oxford, England). 1990;1998(34):347–52.

    Google Scholar 

  62. Dechaphunkul A, Sakdejayont S, Sathitruangsak C, Sunpaweravong P. Clinical characteristics and treatment outcomes of patients with primary mediastinal germ cell tumors: 10-years’ experience at a single institution with a bleomycin-containing regimen. Oncol Res Treat. 2016;39:688–94.

    Article  CAS  PubMed  Google Scholar 

  63. Oizumi H, Suzuki K, Banno T, Matsunaga T, Oh S, Takamochi K. Patency of grafts after total resection and reconstruction of the superior vena cava for thoracic malignancy. Surg Today. 2016;46:1421–6.

    Article  PubMed  Google Scholar 

  64. Kruger I, Borowski A, Horst M, de Vivie ER, Theissen P, Gross-Fengels W. Symptoms, diagnosis, and therapy of primary sarcomas of the pulmonary artery. Thorac Cardiovasc Surg. 1990;38:91–5.

    Article  CAS  PubMed  Google Scholar 

  65. Blackmon SH, Rice DC, Correa AM, Mehran R, Putnam JB, Smythe WR, et al. Management of primary pulmonary artery sarcomas. Ann Thorac Surg. 2009;87:977–84.

    Article  PubMed  Google Scholar 

  66. Mussot S, Ghigna MR, Mercier O, Fabre D, Fadel E, Le Cesne A, et al. Retrospective institutional study of 31 patients treated for pulmonary artery sarcoma. Eur J Cardiothorac Surg. 2013;43:787–93.

    Article  PubMed  Google Scholar 

  67. Grazioli V, Vistarini N, Morsolini M, Klersy C, Orlandoni G, Dore R, et al. Surgical treatment of primary pulmonary artery sarcoma. J Thorac Cardiovasc Surg. 2014;148:113–8.

    Article  PubMed  Google Scholar 

  68. Maruo A, Okita Y, Okada K, Yamashita T, Tobe S, Tanimura N. Surgical experience for the pulmonary artery sarcoma. Ann Thorac Surg. 2006;82:2014–6.

    Article  PubMed  Google Scholar 

  69. Mori S, Uehara H, Motoi N, Okumura S. Pulmonary artery sarcoma presenting as an isolated lung mass. Gen Thorac Cardiovasc Surg. 2017;65:171–4.

    Article  PubMed  Google Scholar 

  70. Tanaka A, Shirasaka T, Okada K, Okita Y. Aggressive multiple surgical interventions to pulmonary artery sarcoma. Eur J Cardiothorac Surg. 2015;47:384–5.

    Article  PubMed  Google Scholar 

  71. Park BJ, Bacchetta M, Bains MS, Downey RJ, Flores R, Rusch VW, et al. Surgical management of thoracic malignancies invading the heart or great vessels. Ann Thorac Surg. 2004;78:1024–30.

    Article  PubMed  Google Scholar 

  72. Langer NB, Mercier O, Fabre D, Lawton J, Mussot S, Dartevelle P, et al. Outcomes after resection of T4 non-small cell lung cancer using cardiopulmonary bypass. Ann Thorac Surg. 2016;102:902–10.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Thoracic Surgery, Department of Surgery, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuou-ku, Kobe, Hyogo, 650-0017, Japan

    Yugo Tanaka, Daisuke Hokka, Hiroyuki Ogawa, Nahoko Shimizu & Yoshimasa Maniwa

  2. Division of Cardiovascular Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan

    Takeshi Inoue, Hiroshi Tanaka & Yutaka Okita

Authors
  1. Yugo Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daisuke Hokka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hiroyuki Ogawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nahoko Shimizu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takeshi Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hiroshi Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yutaka Okita
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yoshimasa Maniwa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoshimasa Maniwa.

Ethics declarations

Conflict of interest

There are no potential conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tanaka, Y., Hokka, D., Ogawa, H. et al. Surgery for malignant lesions of the chest which extensively involved the mediastinum, lung, and heart. Gen Thorac Cardiovasc Surg 65, 365–373 (2017). https://doi.org/10.1007/s11748-017-0782-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11748-017-0782-0

Keywords

Search

Navigation